Your browser doesn't support javascript.
loading
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study.
García-Martín, Paloma; Díez, Ana Moñiz; Maldonado, José Manuel Sánchez; Serrano, Antonio José Cabrera; Ter Horst, Rob; Benavente, Yolanda; Landi, Stefano; Macauda, Angelica; Clay-Gilmour, Alyssa; Hernández-Mohedo, Francisca; Niazi, Yasmeen; González-Sierra, Pedro; Espinet, Blanca; Rodríguez-Sevilla, Juan José; Maffei, Rossana; Blanco, Gonzalo; Giaccherini, Matteo; Puiggros, Anna; Cerhan, James; Marasca, Roberto; Cañadas-Garre, Marisa; López-Nevot, Miguel Ángel; Chen-Liang, Tzu; Thomsen, Hauke; Gámez, Irene; Moreno, Víctor; Marcos-Gragera, Rafael; García-Álvarez, María; Llorca, Javier; Jerez, Andrés; Berndt, Sonja; Butrym, Aleksandra; Norman, Aaron D; Casabonne, Delphine; Luppi, Mario; Slager, Susan L; Hemminki, Kari; Li, Yang; Alcoceba, Miguel; Campa, Daniele; Canzian, Federico; de Sanjosé, Silvia; Försti, Asta; Netea, Mihai G; Jurado, Manuel; Sainz, Juan.
Afiliação
  • García-Martín P; Hospital Campus de la Salud, PTS Granada, Granada, Spain.
  • Díez AM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.
  • Maldonado JMS; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Serrano AJC; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Ter Horst R; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.
  • Benavente Y; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Landi S; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Macauda A; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.
  • Clay-Gilmour A; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Hernández-Mohedo F; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Niazi Y; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
  • González-Sierra P; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Espinet B; Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) and University of Barcelona, Barcelona, Spain.
  • Rodríguez-Sevilla JJ; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Maffei R; Department of Biology, University of Pisa, Pisa, Italy.
  • Blanco G; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Giaccherini M; Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Greenville, SC, USA.
  • Puiggros A; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Cerhan J; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Marasca R; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Cañadas-Garre M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • López-Nevot MÁ; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Chen-Liang T; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Thomsen H; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Gámez I; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Moreno V; Hematology Department, Hospital del Mar, Barcelona, Spain.
  • Marcos-Gragera R; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
  • García-Álvarez M; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Llorca J; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Jerez A; Department of Biology, University of Pisa, Pisa, Italy.
  • Berndt S; Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar, Barcelona, Spain.
  • Butrym A; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
  • Norman AD; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 55905, USA.
  • Casabonne D; Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, AOU Policlinico, Modena, Italy.
  • Luppi M; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, Spain.
  • Slager SL; Hematology department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Hemminki K; Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
  • Li Y; Immunology Department, Virgen de las Nieves University Hospital, Granada, Spain.
  • Alcoceba M; Hematology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • Campa D; ProtaGene CGT GmbH, Heidelberg, Germany.
  • Canzian F; Hematology Department, Morales Meseguer University Hospital, Murcia, Spain.
  • de Sanjosé S; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Försti A; Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, IDIBELL, Catalan Institute of Oncology; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Netea MG; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Jurado M; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona Biomedical Research Institute (IdiBGi), and Universitat de Girona, Girona, Spain.
  • Sainz J; Josep Carreras Leukemia Research Institute, Girona, Spain.
Blood Cancer J ; 12(5): 79, 2022 05 17.
Article em En | MEDLINE | ID: mdl-35581176
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha